{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T16:22:16Z","timestamp":1649175736315},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharm World Sci"],"published-print":{"date-parts":[[2007,7,26]]},"DOI":"10.1007\/s11096-007-9085-3","type":"journal-article","created":{"date-parts":[[2007,2,28]],"date-time":"2007-02-28T03:24:11Z","timestamp":1172633051000},"page":"350-352","source":"Crossref","is-referenced-by-count":1,"title":["Tuberous sclerosis successfully treated with levetiracetam monotherapy: 18 months of follow-up"],"prefix":"10.1007","volume":"29","author":[{"given":"Savvas S.","family":"Papacostas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleftherios S.","family":"Papathanasiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panayiota","family":"Myrianthopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Goula","family":"Stylianidou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,3,1]]},"reference":[{"issue":"13","key":"9085_CR1","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJMra055323","volume":"355","author":"PB Crino","year":"2006","unstructured":"Crino PB, Nathanson KL, Henske EP. The tuberous sclerosis complex. N Engl J Med 2006;355(13):1345\u20131356","journal-title":"N Engl J Med"},{"issue":"8","key":"9085_CR2","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1007\/s00381-006-0130-7","volume":"22","author":"MB Connoly","year":"2006","unstructured":"Connoly MB, Hendson G, Steinbok P. Tuberous sclerosis complex: a review of the management of epilepsy with emphasis on surgical aspects. Childs Nerv Syst 2006;22(8):896\u2013908","journal-title":"Childs Nerv Syst"},{"key":"9085_CR3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0304-3940(01)01884-5","volume":"306","author":"I Niespodziany","year":"2001","unstructured":"Niespodziany I, Klitgaard H, Margineanu D-G. Levetiracetam inhibits the high-voltage activated Ca2\u00a0+\u00a0 current in pyramidal neurons of rat hippocampal slices. Neurosci Lett 2001;306:5\u20138","journal-title":"Neurosci Lett"},{"key":"9085_CR4","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/sj.bjp.0704766","volume":"136","author":"JM Rigo","year":"2000","unstructured":"Rigo JM, Hans G, Nguyen L, et al. The anti-epileptic drug levetiracetam reverses the inhibition by negative allosteric modulators of neuronal GABA- and glycine-gated current. Br J Pharmacol 2000;136:659\u2013672","journal-title":"Br J Pharmacol"},{"issue":"26","key":"9085_CR5","doi-asserted-by":"crossref","first-page":"9861","DOI":"10.1073\/pnas.0308208101","volume":"101","author":"BA Lynch","year":"2004","unstructured":"Lynch BA, Lambeng N, Nocka K, Kensel-Hammes P, Bajjalieh SM, Matagne A, Fuks B. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci U S A. 2004;101(26):9861\u20136 Jun 29","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"9085_CR6","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/08830738060210011201","volume":"21","author":"JJ Collins","year":"2006","unstructured":"Collins JJ, Tudor C, Leonard JM, Chuck G, Franz DN. Levetiracetam as adjunctive antiepileptic therapy for patients with tuberous sclerosis complex: a retrospective open-label trial. J Child Neurol. 2006;21(1):53\u20137 Jan","journal-title":"J Child Neurol"},{"issue":"3","key":"9085_CR7","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.seizure.2005.12.004","volume":"15","author":"A Labate","year":"2006","unstructured":"Labate A, Colosimo E, Gambardella A, et al. Levetiracetam in patients with generalized epilepsy and myoclonic seizures: an open label study. Seizure 2006;15(3):214\u20138","journal-title":"Seizure"},{"key":"9085_CR8","doi-asserted-by":"crossref","unstructured":"Coppola G, Franzoni E, Verrotti A, Garone C, Sarajlija J, Felicia Operto F, Pascotto A. Levetiracetam or oxcarbazepine as monotherapy in newly diagnosed benign epilepsy of childhood with centrotemporal spikes (BECTS): an open-label, parallel group trial. Brain Dev 2006; Oct 19","DOI":"10.1016\/j.braindev.2006.09.008"},{"key":"9085_CR9","first-page":"77","volume":"85","author":"JC Cloyd","year":"2000","unstructured":"Cloyd JC, Remmel RP. Antiepileptic drug pharmacokinetics and interactions: impact on treatment of epilepsy. Pharmacotherapy 2000;85:77\u201385","journal-title":"Pharmacotherapy"},{"issue":"9","key":"9085_CR10","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1111\/j.1528-1167.2005.29604.x","volume":"46","author":"C Ji-qun","year":"2005","unstructured":"Ji-qun C, Ishihara K, Nagayama T, et al. Long-lasting antiepileptic effects of levetiracetam against epileptic seizures in the spontaneously epileptic rat (SER): differentiation of levetiracetam from conventional antiepileptic drugs. Epilepsia 2005;46(9):1362\u20131370","journal-title":"Epilepsia"}],"container-title":["Pharmacy World & Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-007-9085-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11096-007-9085-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-007-9085-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T01:51:30Z","timestamp":1559353890000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11096-007-9085-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3,1]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,7,26]]}},"alternative-id":["9085"],"URL":"https:\/\/doi.org\/10.1007\/s11096-007-9085-3","relation":{},"ISSN":["0928-1231","1573-739X"],"issn-type":[{"value":"0928-1231","type":"print"},{"value":"1573-739X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,3,1]]}}}